The RISE consortium is composed of researchers from University of Washington, Vanderbilt University Medical Center, and Geisinger. Our multidisciplinary team combines expertise in precision medicine, implementation science, population genetics, and statistical and economic modeling.

Principal Investigators

Vanderbilt University Medical Center

    Josh Peterson MD, MPH, FACMI, FAMIA

      Vanderbilt University Medical Center

      Dr. Peterson is an internationally recognized researcher and educator in Biomedical Informatics and maintains an Internal Medicine practice at VUMC. He has authored more than 120 peer-reviewed publications, abstracts, reviews, and book chapters.

      Dr. Peterson’s research interests are in precision medicine with a focus on clinical decision support to improve drug safety and efficacy, and the translation of genomic technologies to routine clinical care. He has led the design and implementation of multiple clinical decision support systems oriented towards geriatric patients, the critically ill, patients with acute and chronic kidney disease, and most recently for patients tested within a large pharmacogenomics implementation - PREDICT.

      He currently serves as a principal investigator for an NIH funded project to simulate the clinical impact and cost-effectiveness of performing sequencing across large populations over their lifetime. He is also active within a variety of NIH sponsored research consortia including, eMERGE where he leads the Coordinating Center, and IGNITE where he is principal investigator of the I3P clinical sites recruiting for Genomic Medicine randomized clinical trials.

      Dr. Peterson was the founding Program Director for the Masters of Applied Clinical Informatics (MSACI) program, which trains physicians and other health professionals in the field of Clinical Informatics. He currently directs the Vanderbilt Genomic Medicine training program.

      Jing Hao PhD, MD, MS, MPH


        Dr. Hao is an Associate Professor at Department of Population Health Sciences and Department of Genomic Health at Geisinger. Her research focuses on economic evaluation and health services research on healthcare programs that aim to improve patient outcomes through promoting personalized/precision health, especially in areas of cancer and ASCVD screening and prevention and genomic sequencing. She serves as MPI, site-PI and co-Investigator on multiple NIH funded R01 and U01 projects in the field. Dr. Hao is serving in a leadership role at the Precision Medicine and Advanced Therapies Scientific Interest Group (SIG) at ISPOR. She is a recipient of the 2017 Early Career Investigator Award from the Health Care Systems Research Network (HCSRN).

          The quantitative research methods she uses include decision analysis modeling and simulation, biostatistics and econometrics methods by utilizing electronic health records, claims data, both internal and national cost data sources and by systematic evidence synthesis.

          University of Washington

            David Veenstra PhD, PharmD

              University of Washington

              Dr. Veenstra is a Professor in the Department of Pharmacy and Associate Director of the Comparative Health Outcomes, Policy & Economics (CHOICE) Institute. He graduated from the University of California San Francisco with doctoral degrees in clinical pharmacy and computational chemistry. He conducted his postdoctoral training in health economics and outcomes research with the University of Washington, including a one-year externship with Roche Global Pharmacoeconomics.

              Dr. Veenstra’s primary research interests are the clinical, economic, and policy implications of using genomic information in healthcare. His major research projects include evaluation of the cost effectiveness of population-level genomic screening, pharmacogenomics in diverse populations, decision modeling techniques to assess evidence thresholds, and stakeholder preferences for precision medicine.

              Dr. Veenstra’s research has been funded through grants from the National Human Genome Research Institute, Centers for Disease Control, National Cancer Institute, and the National Institute for General Medical Sciences.

              Dr. Veenstra has worked extensively with organizations such as the Academy of Managed Care Pharmacy (AMCP) and the Institute for Clinical and Economic Review (ICER) to further the practical application of cost-effectiveness analysis in managed care decision making.

              Dr. Veenstra teaches courses in pharmacoeconomics and managed care and is an author or co-author of five book chapters and over 180 peer-reviewed publications.


              Vanderbilt University Medical Center
              John Graves, PhD
              Shawn Garbett, MS
              Johnathan S. Schildcrout, PhD
              Jinyi Zhu, PhD, MPH
              Marc S. Williams, MD
              Laney Jones, PharmD, MPH

              Associate Professor at Geisinger's Department of Genomic Health

              Katrina M. Romagnoli, PhD, MS, MLIS

              Assistant Professor, Department of Health System Sciences

              Matthew Oetjens, PHD

              Assistant Professor, Autism and Developmental Medicine Institute

              Alexander S. Berry

              Staff Scientist, Autism and Developmental Medicine Institute

              Alicia M. Johns, PhD

              Biostatistician, Department of Population Health Sciences

              Dina Hassen, MPP

              Biostatistical Analyst III

              University of Washington
              Greg Guzauskas, PhD
              Joyce Jiang, MPH